OBJECTIVE: To develop a method for determining the acceptability and safety of ready-to-use therapeutic foods (RUTF) before clinical trialing.
There are approximately 225-600 million new malaria infections worldwide annually, with severe and cerebral malaria representing major causes of death internationally.
Few studies have looked at consumption of Ready-to-Use-Supplementary-Foods (RUSFs) during a nutritional emergency.
OBJECTIVE: To assess the effectiveness of blood transfusions in a hospital of north-eastern Democratic Republic of the Congo.
In the face of spreading chloroquine and sulfadoxine-pyrimethamine (SP) resistance, amodiaquine remains a cheap and efficacious alternative for treating uncomplicated Plasmodium falciparum malaria in many settings.
UNLABELLED:
BACKGROUND: The mental health needs of young children in humanitarian contexts often remain unaddressed.
UNLABELLED:
Nature has established two mechanistically and structurally unrelated families of thymidylate synthases that produce de novo thymidylate or dTMP, an essential DNA precursor.
